Birth control
The only officially FDA-approved use for Kyleena is as a birth control measure. The Kyleena IUD is a small device that fits into the uterus. It is used to prevent pregnancy in women. The primary idea of this position is to release certain hormones directly into the uterus, which may yield more effective results than oral contraceptives. By placing the device into the uterus, there is also no need for concern about taking a pill daily. The patient will keep the device in their uterus for up to five years. At this time, the patient can decide whether or not they want to continue using birth control to prevent pregnancy.
As a birth control measure to prevent pregnancy, Kyleena is only approved for women of childbearing age. No studies have been done on patients younger than 18 years of age. The product also does not require further use once the woman experiences menopause, as she will no longer be childbearing.
Endometrial hyperplasia
While the FDA has only approved Kyleena as a birth control method, some off-label uses have been reported. The levonorgestrel-releasing intrauterine system may be prescribed for similar off-label reasons as other hormonal birth control options. Some researchers have suggested that Kyleena might effectively treat endometrial hyperplasia.
Endometrial hyperplasia is a condition that can only affect women. It is related to the reproductive system and affects the endometrium, the lining that forms part of the uterus. The condition causes a thickening of this lining, which can result in excessive bleeding. The effect happens due to an excessive amount of cells in the area. Heavy periods and vaginal bleeding are two of the most common symptoms of endometrial hyperplasia.
In one study, researchers looked at the potential of the Kyleena IUD as a treatment option for endometrial hyperplasia. Each patient had a Kyleena IUD device placed inside their uterus during the study. These clinical trials found improvements in the signs associated with endometrial hyperplasia among the women in the study. The symptoms that the female patients experienced were also reduced. The study did not focus on preventing pregnancy but on treating this condition.